PROXY STATEMENT
________________
SILICOM LTD.
14 Atir Yeda St.
Kfar Sava
Israel
ANNUAL GENERAL MEETING OF SHAREHOLDERS
June 18, 2024
The enclosed proxy is being solicited by the board of directors (the “Board of Directors”) of Silicom Ltd. (the “Company”) for use at the Company's Annual General Meeting of Shareholders (the “Meeting”) to be held on June 18, 2024, at 14:00 Israel time, or at any adjournment or
postponement thereof. Upon the receipt of a properly executed proxy in the form enclosed, the persons named as proxies therein will vote the ordinary shares, par value New Israeli Shekels (“NIS”) 0.01 each, of
the Company (the “Ordinary Shares”) covered thereby in accordance with the directions of the shareholders executing the proxy. In the absence of such directions, and except as mentioned otherwise in this proxy
statement, the Ordinary Shares represented thereby will be voted in favor of each of the proposals described in this proxy statement.
The proxy solicited hereby may be revoked at any time prior to its exercise, by means of a written notice delivered to the Company, by substitution of a new proxy bearing a
later date or by a request for the return of the proxy at the Meeting. The Company expects to solicit proxies by mail and to mail this proxy statement and the accompanying proxy card to shareholders on or about May 13, 2024. Directors, officers, and
employees of the Company may also solicit proxies by telephone, facsimile and personal interview.
The Company will bear the cost of the preparation and mailing of its proxy materials and the solicitation of proxies. Copies of solicitation materials will be furnished to
brokerage firms, nominees, fiduciaries and other custodians for forwarding to their principals, and the reasonable fees and expenses of such forwarding agents will be borne by the Company. Only holders of record of Ordinary Shares at the close of
business in New York, NY, USA on May 10, 2024, are entitled to vote at the Meeting. On April 30, 2024, 6,098,926 Ordinary Shares were outstanding and entitled to vote. Each Ordinary Share is entitled to one vote on each matter to be voted at the
Meeting.
Two or more shareholders present, personally or by proxy, holding not less than thirty three and a third percent (33 1/3%) of the Company's outstanding Ordinary Shares, shall
constitute a quorum for the Meeting. If within half an hour from the time the Meeting is convened a quorum is not present, the Meeting shall stand adjourned until June 25, 2024 at 14:00 Israel time. If a quorum
is not present at the adjourned Meeting within half an hour from the time appointed for such meeting, two or more shareholders present personally or by proxy shall be deemed a quorum, and shall be entitled to deliberate and to resolve in respect of
the matters for which the Meeting was convened. Abstentions and broker non-votes are counted as Ordinary Shares present for the purpose of determining a quorum.
Pursuant to the Israeli Companies Law, 1999-5759 (the “Companies Law”), each of Proposals 1, 2, 3, 5, 6 and 7 requires the affirmative
vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary Shares of the Company amounting in the aggregate to at least a majority of the votes actually cast by shareholders with respect to such proposals (hereinafter an
“Ordinary Majority”).
Pursuant to the Companies Law, Proposal 4 requires the affirmative vote of a simple majority of shares present at the Meeting, in person or by proxy, and voting thereon, as long
as either:
|
• |
the majority of shares that voted for the approval of the proposal includes at least majority of the shares held by non-controlling and non-interested shareholders voted at the Meeting, (excluding abstaining votes); or
|
|
• |
the total number of shares of non-controlling and non-interested shareholders that voted against the approval of the proposal does not exceed two percent of the aggregate voting rights in the Company, (the “Disinterested
Majority Vote”).
|
Shareholders are requested to notify us whether or not they have a "Personal Interest" in connection with Proposal 4 (please see the definition of the term "Personal Interest"
with respect to such proposal, and the procedure for ensuring that your vote is counted, under the description of Proposal 4 below).
PRINCIPAL SHAREHOLDERS
The following table sets forth, as of April 30, 2024, the number of Ordinary Shares, including options and warrants to purchase Ordinary Shares exercisable within 60 days, owned
by (i) all shareholders known to the Company to own more than five percent (5%) of the Company's Ordinary Shares and (ii) all directors and officers as a group (based on 6,098,926 Ordinary Shares outstanding on that date). Each of our shareholders
has identical voting rights with respect to its shares. All of the information with respect to beneficial ownership of the Ordinary Shares is given to the best of our knowledge. Except where otherwise indicated, and subject to applicable community
property laws, we believe, based on information furnished to us by such owners or otherwise disclosed in any public filings, that the beneficial owners of the Ordinary Shares listed below have sole dispositive and voting power with respect to such
Ordinary Shares.
|
Name of Shareholder
|
Number of Shares and Options Owned(1)
|
Percentage of Outstanding Shares
|
|
Systematic Financial Management, LP(3)
|
619,912
|
10.16%
|
|
Wellington Management Group LLP(2)
|
507,178
|
8.32%
|
|
First Wilshire Securities Management, Inc.(4)
|
499,563
|
8.19%
|
| (1) |
The table above includes the number of shares and options that are exercisable within 60 days of April 30, 2024. Ordinary shares subject to these options are deemed beneficially owned for the purpose of computing the ownership percentage
of the person or group holding these options, but are not deemed outstanding for purposes of computing the ownership percentage of any other person. Except where otherwise indicated, and subject to applicable community property laws, based on
information furnished to us by such owners or otherwise disclosed in any public filings, to our knowledge, the persons and entities named in the table have sole voting and dispositive power with respect to all shares shown as beneficially
owned by them. All the information detailed in this table is as set forth in major shareholders' public filings, unless stated otherwise.
|
| (2) |
As reported on Schedule 13G/A filed by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP with the SEC on February 8, 2024. The securities as to
which the Schedule was filed are owned of record by clients of one or more investment advisers, which are directly or indirectly owned by Wellington Management Group LLP, the identities of which are set forth in Exhibit A of such Schedule
13G/A.
|
Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have
such right or power with respect to more than 5% of this class of securities, except for: Wellington Trust Company, NA (“Wellington”).
As reported on Schedule 13G/A filed by Wellington with the SEC on February 8, 2024, those securities as to which the Schedule was filed by Wellington, in its capacity as investment
adviser, are owned of record by its clients. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have such right or power with
respect to more than five percent of this class of securities.
| (3) |
As reported on Schedule 13G filed by Systematic Financial Management, LP with the SEC on February 13, 2024.
|
| (4) |
As reported on Schedules 13G/A filed by First Wilshire Securities Management, Inc. with the SEC on February 12, 2024.
|
COMPENSATION OF OFFICERS
For details concerning the compensation granted to the Company's five most highly compensated office holders (as defined in the Companies Law) during or with respect to the year
ended December 31, 2023, see the Company's annual report on Form 20-F filed with the Securities and Exchange Commission on April 30, 2024.
BOARD DIVERSITY MATRIX (AS OF MAY 2, 2024)
Country of Principal Executive Office - Israel
Foreign Private Issuer - Yes
Disclosure Prohibited under Home Country Law - No
Total Number of Directors – 5
Part I: Gender Identity
|
|
Female
|
Male
|
Non-Binary
|
Did Not Disclose Gender
|
|
Directors
|
1
|
4
|
0
|
0
|
Part II: Demographic Background
|
Underrepresented Individual in Home Country Jurisdiction
|
0
|
|
LGBTQ+
|
0
|
|
Did Not Disclose Demographic Background
|
0
|
* * * * *
PROPOSAL 1
TO RE-ELECT MR. AVI EIZENMAN TO HOLD OFFICE AS DIRECTOR FOR A THREE-
YEAR TERM COMMENCING ON THE DATE OF THE MEETING
The management of the Company has selected Mr. Avi Eizenman, the Active Chairman of the Board for re-election as director to serve for an additional three-year term commencing on
the date of the Meeting until the end of his term and until his successor is duly elected. In the absence of instructions to the contrary, the persons named in the enclosed proxy will vote the Ordinary Shares represented thereby "FOR" the election of
Mr. Avi Eizenman. If Mr. Avi Eizenman is unable to serve, the persons named in the proxy shall vote the Ordinary Shares for the election of such other nominee as management may propose. Mr. Avi Eizenman, who is currently serving as a director of the
Company, has advised the Company that he will continue to serve as director if re-elected.
Mr. Avi Eizenman has attested to the Board of Directors and the Company that he meets all the requirements in connection with the election of directors of publicly traded
companies under the Companies Law and the regulations promulgated thereunder.
The following table provides certain relevant information concerning Mr. Avi Eizenman, including his principal occupation during the past five years.
|
Nominee
|
Age
|
Principal Occupation
|
| |
|
|
|
Avi Eizenman
|
66
|
Mr. Eizenman co-founded the Company in 1987 and has served as a Director since its inception. Mr. Eizenman also served as our President and Chief Executive Officer from the Company's
inception until April 1, 2001, and on such date, he resigned from his positions as President and Chief Executive Officer and was appointed Active Chairman of the Board of Directors. Before the incorporation of Silicom, Mr. Eizenman held
various engineering and management positions at Scitex Ltd. and at the Electronic Research & Development Department of the Israeli Ministry of Defense. Mr. Eizenman holds a B.Sc. degree, with honors, in Electrical Engineering from the
Technion, and an M.B.A. from Tel Aviv University.
|
In accordance with our Compensation Policy which was re-approved by the Company’s Compensation Committee and Board of Directors on June 12, 2022 (the "Compensation Policy"), Mr. Avi Eizenman will continue to be a party to an indemnification agreement with the Company in the form of the indemnification letter previously approved by the shareholders on April 11, 2012 to be entered
into by the Company with directors serving from time to time in such capacity (the “Indemnification Agreement”), and shall continue to be insured under the Company’s directors and officers insurance coverage
which provides coverage for all directors of the Company. Under our Compensation Policy, any change to the indemnification agreement or the insurance policy, including the cost and/or any changes which materially depart from the key terms of the
current agreement and/or insurance policy (provided that such changes apply equally to all executives of the Company, including directors) will be submitted to the Company's Compensation Committee and the Board of Directors for their approval but
shall not, unless required by law or the Company's Articles of Association, be presented at a General Meeting of the shareholders.
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED, to re-elect Mr. Avi Eizenman as a director of the Company for a three-year term commencing on the date of the Meeting and until his successor has been
duly elected.”
The re-election of Mr. Avi Eizenman as director requires the affirmative vote of an Ordinary Majority.
The Board of Directors, with the exception of Mr. Avi Eizenman who expresses no recommendation as to the vote on the above proposal,
recommends a vote FOR approval of the re-election of Mr. Avi Eizenman as a director of the Company as set forth above.
PROPOSAL 2
TO RE-ELECT MR. ELI DORON TO HOLD OFFICE AS DIRECTOR FOR A THREE-
YEAR TERM COMMENCING ON THE DATE OF THE MEETING
The management of the Company has selected Mr. Eli Doron for re-election as director to serve for an additional three-year term commencing on the date of the Meeting until the end
of his term and until his successor is duly elected. In the absence of instructions to the contrary, the persons named in the enclosed proxy will vote the Ordinary Shares represented thereby "FOR" the election of Mr. Doron. If Mr. Doron is unable to
serve, the persons named in the proxy shall vote the Ordinary Shares for the election of such other nominee as management may propose. Mr. Doron, who is currently serving as a director of the Company, has advised the Company that he will continue to
serve as director if re-elected.
Mr. Eli Doron has attested to the Board of Directors and the Company that he meets all the requirements in connection with the election of directors of publicly traded companies
under the Companies Law and the regulations promulgated thereunder.
The following table provides certain relevant information concerning Mr. Doron, including his principal occupation during the past five years.
|
Nominee
|
Age
|
Principal Occupation
|
| |
|
|
|
Eli Doron
|
66
|
Mr. Doron is the co-founder and CTO of Carteav, that develops and manufactures an autonomous low speed vehicle. Eli Doron is also the founder of Connesta Ltd. ("Connesta"), an Israeli
high-tech company engaged in developing and providing SaaS virtual control room solutions, founded in 2011. From inception, Mr. Doron serves as the Chief Executive Officer of Connesta. Prior thereto and during 2010, Mr. Doron was the Chief
Executive Officer of Computerized Electricity Systems ("CES"). Prior to joining CES, Mr. Doron was the co-founder of Radvision Ltd. (formerly NASDAQ: RVSN. Acquired by Avaya Ltd. in 2011; "Radvision"). From 1992 and until 2009 Mr. Doron
served as the Chief Technology Officer of Radvision, and from 2006 and until 2009 he served as President of Radvision. Prior to founding Radvision and from 1983, Mr. Doron served at SIMTECH Advanced Training and Simulation Systems Ltd.,
initially as hardware manager and from 1988 as Chief Technology Officer. Prior thereto and from 1977, Mr. Doron served as an electronic engineer at MBT Israel Aircraft Industries Ltd. Mr. Doron holds a B.Sc degree in electronics and computer
science from Ben-Gurion University and an M.B.A. degree from the University of Bradford in the United Kingdom.
|
In accordance with our Compensation Policy, Mr. Doron will continue to be a party to an Indemnification Agreement, and shall continue to be insured under the Company’s directors
and officers insurance coverage which provides coverage for all directors of the Company.
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED, to re-elect Mr. Eli Doron as a director of the Company for a three-year term commencing on the date of the Meeting and until his successor has been
duly elected.”
The re-election of Mr. Doron as director requires the affirmative vote of an Ordinary Majority.
The Board of Directors, with the exception of Mr. Doron who expresses no recommendation as to the vote on the above proposal, recommends
a vote FOR approval of the re-election of Mr. Doron as a director of the Company as set forth above.
PROPOSAL 3
TO APPROVE A FRAMEWORK FOR THE GRANTING OF RESTRICTED STOCK UNITS
TO MR. YESHAYAHU ('SHAIKE') ORBACH
Since July 1, 2022 Mr. Orbach has served as the Executive Vice Chairman of the Board following his stepping down as our President and CEO and head of sales and marketing. On
November 1, 2023 the Company has requested, and Mr. Orbach agreed to spend 25% of his time assisting the Company with its sales activities (the “Services”), until such time as either the Company or Mr. Orbach
decide to terminate the Services. In light of these increased efforts and time spent, our Compensation Committee and Board of Directors recommended and approved, subject to shareholder approval, a framework
for granting Restricted Stock Units (“RSUs”) to Mr. Orbach under the Company's Global Share Incentive Plan (2013) (the “Plan”), pursuant to which in which Mr. Orbach may
be granted from time to time (i) an aggregate of up to 5,000 RSUs under the Plan, upon terms to be determined by the Compensation Committee and Board of Directors, in consideration for his providing the Services during the period commencing November
1, 2023 and ending October 31, 2024, and (ii) an aggregate of up to a further 5,000 RSUs under the Plan, upon terms to be determined by the Compensation Committee and Board of Directors, in consideration for his providing the Services during the
period commencing November 1, 2024 and ending October 31, 2025 (the framework described in (i) and (ii) above, the “RSU Framework”). All grants will be made in compliance with the Company's Compensation Policy
and the limitations applicable to employee directors of the Company which the Compensation Committee and Board of directors concluded are applicable to the provision of the Services by Mr. Orbach.
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED to authorize the Compensation Committee and Board of Directors to grant Mr. Yeshayahu (‘Shaike’) Orbach from
time to time, (i) an aggregate of up to 5,000 RSUs, under the Plan, in consideration for his providing the Services during the period commencing November 1, 2023 and ending October 31, 2024, and (ii) an aggregate of up to a further 5,000 RSUs under
the Plan, in consideration for his providing the Services during the period commencing November 1, 2024 and ending October 31, 2025, in each case upon terms to be determined by the Compensation Committee and Board of Directors; and provided that
any grant shall be in compliance with the Compensation Policy and the and the limitations applicable to employee directors of the Company.”
The approval of the RSU Framework requires the affirmative vote of an Ordinary Majority.
The Board of Directors, with the exception of Mr. Orbach who expresses no recommendation as to the vote on the above proposal,
recommends that the shareholders vote FOR approval of the proposed resolution.
PROPOSAL 4
TO APPROVE THE GRANT OF 100,000 OPTIONS TO PURCHASE ORDINARY SHARES
OF THE COMPANY TO MR. LIRON EIZENMAN, PRESIDENT AND CHIEF EXECUTIVE
OFFICER OF THE COMPANY
Our Compensation Committee and Board of Directors have each recommended and approved, a grant of 100,000 options to purchase Ordinary Shares (“Options”)
pursuant to the Plan to Mr. Liron Eizenman, President and Chief Executive Officer of the Company.
The Compensation Committee and Board of Directors have each also determined that the proposed grant of Options to Mr. Liron Eizenman is in compliance with the Compensation Policy
and the Cap. The proposed grant has an exercise price equal to the average closing price of the Company's Ordinary Shares on the 30 trading days preceding the date of this Meeting, which shall be considered the “Grant Date”, where 50% will vest on
the second anniversary of the Grant Date and 50% will vest on the third anniversary of the Grant Date, and which options (vested and unvested) shall expire, by their terms, upon the eighth anniversary of the Grant Date.
The Compensation Committee and Board of Directors have each concluded that the terms of the proposed grant of options are pursuant to the Plan and are in compliance with the
Compensation Policy and the Cap.
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED, to approve granting 100,000 Options to Mr. Liron Eizenman, President and Chief Executive Officer of the Company, pursuant to
the Plan, with the effective grant date and vesting terms as set forth above.”
Pursuant to the Companies Law, approval of Proposal 4 requires the affirmative vote of a simple majority of shares present at the meeting, in person or by proxy, and voting
thereon, as long as one of the following conditions is met:
|
• |
the majority of shares voted for the proposal includes at least a majority of the shares held by non-controlling and non-interested shareholders, and voted at the meeting (excluding abstaining votes); or
|
|
• |
the total number of shares of non-controlling and non-interested shareholders voted against the proposal does not exceed two percent of the aggregate voting rights in the company.
|
Each shareholder voting at the meeting or prior thereto by means of the accompanying proxy card is requested to notify us if he, she or it has a Personal Interest in connection
with this Proposal 4 as a condition for his or her vote to be counted with respect to this Proposal 4.
For this purpose, “Personal Interest” is defined as: (1) a shareholder's personal interest in the approval of an act or a transaction of the Company, including (i) the personal
interest of his or her relative (which includes for these purposes any members of his/her (or his/her spouse's) immediate family or the spouses of any such members of his or her (or his/her spouse's) immediate family); and (ii) a personal interest of
a body corporate in which a shareholder or any of his/her aforementioned relatives serves as a director or the chief executive officer, owns at least five percent (5%) of its issued share capital or its voting rights or has the right to appoint a
director or chief executive officer, but (2) excluding (i) a personal interest arising solely from the fact of holding shares in the Company or in a body corporate; or (ii) a personal interest that is not a result of connections with a controlling
shareholder of the Company. Please note that we consider it highly unlikely that any of our public shareholders has a personal interest in this Proposal 4. However, as
required under Israeli law, the enclosed proxy requires that you specifically indicate whether you have a Personal Interest in this proposal. If you do not indicate to this effect – we will not be able to count your vote with respect to the
Disinterested Majority Vote required for the approval of this Proposal 4.
The Board of Directors, with the exception of Mr. Avi Eizenman who expresses no recommendation as to the vote on the above proposal, recommends that the
shareholders vote FOR approval of the proposed resolution.
PROPOSAL 5
TO APPROVE THE GRANT OF 60,000 OPTIONS TO PURCHASE ORDINARY SHARES
OF THE COMPANY TO MR. AVI EIZENMAN, ACTIVE CHAIRMAN OF THE BOARD OF
DIRECTORS OF THE COMPANY
Our Compensation Committee and Board of Directors have each recommended and approved, a grant of 60,000 Options pursuant to the Plan to Mr. Avi Eizenman, Active Chairman of the
Board of Directors of the Company.
The Compensation Committee and Board of Directors have each also determined that the proposed grant of Options to Mr. Avi Eizenman is in compliance with the Compensation Policy
and the Cap. The proposed grant has an exercise price equal to the average closing price of the Company's Ordinary Shares on the 30 trading days preceding the date of this Meeting, which shall be considered the “Grant Date”, where 50% will vest on
the second anniversary of the Grant Date and 50% will vest on the third anniversary of the Grant Date, and which options (vested and unvested) shall expire, by their terms, upon the eighth anniversary of the Grant Date.
The Compensation Committee and Board of Directors have each concluded that the terms of the proposed grant of options are pursuant to the Plan and are in compliance with the
Compensation Policy and the Cap.
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED, to approve granting 60,000 Options to Mr. Avi Eizenman, Active Chairman of the Board of Directors of the Company, pursuant to the Plan, with the
effective grant date and vesting terms as set forth above.”
Pursuant to the Companies Law, approval of Proposal 5 requires the affirmative vote of an Ordinary Majority.
The Board of Directors, with the exception of Mr. Avi Eizenman who expresses no recommendation as to the vote on the above proposal, recommends that the
shareholders vote FOR approval of the proposed resolution.
PROPOSAL 6
TO CONSIDER AND ACT UPON A PROPOSAL TO APPROVE THE ADOPTION OF AN
APPENDIX TO THE PLAN FOR U.S. TAXPAYERS
At a meeting in October 2023, our Board of Directors approved the extension of the Company’s Share Option Plan (2013) for a further ten years. In light of the extension, the Board
of Directors also approved the application of the Company’s existing appendix for US taxpayers, to the extended Plan, in the form attached hereto as Exhibit A (the “US Appendix”).
The shareholders of the Company will be requested to adopt the following resolution at the Meeting:
“RESOLVED, to approve the US Appendix to the extended Plan.”
The approval of the US Appendix to the extended Plan requires the affirmative vote of an Ordinary Majority.
The Board of Directors recommends that the shareholders vote FOR approval of the proposed resolution.
PROPOSAL 7
APPOINTMENT OF KESSELMAN & KESSELMAN CERTIFIED PUBLIC
ACCOUNTANTS (Isr.), PWC ISRAEL, AS INDEPENDENT PUBLIC ACCOUNTANTS OF
THE COMPANY AND AUTHORIZATION OF AUDIT COMMITTEE TO FIX THE
COMPENSATION OF SUCH AUDITORS
Under the Israeli Companies Law, the appointment of independent public accountants requires the approval of the shareholders of the Company.
Following the recommendation and approval of the Audit Committee, the Board of Directors has authorized and approved the appointment of the accounting firm of Kesselman &
Kesselman Certified Public Accountants (Isr.), PwC Israel (“PwC Israel”), as the independent certified public accountants of the Company for the year ending December 31, 2024, and until the next annual general
meeting of the shareholders of the Company.
The Audit Committee and Board of Directors believe that the selection of PwC Israel as the independent accountants of the Company is appropriate and in the best interest of the
Company and its shareholders. Subject to the approval of this Proposal 7, the Audit Committee will be authorized to set the compensation of such auditors in accordance with the volume and nature of their services.
The shareholders of the Company are requested to adopt the following resolution:
“RESOLVED, to appoint PwC Israel as the independent public accountants of the Company for the year ending December 31, 2024, and until the next
annual general meeting of the Company's shareholders, and to authorize the Audit Committee to set their compensation in accordance with the volume and nature of their services.”
The appointment of PwC Israel as the independent public accountants of the Company for the year ending December 31, 2024, and until the next annual general meeting of the Company's
shareholders and authorization of the Audit Committee to set their compensation in accordance with the volume and nature of their services, requires the affirmative vote of an Ordinary Majority.
The Board of Directors recommends that the shareholders vote FOR approval of the proposed resolution.
REVIEWING THE COMPANY'S FINANCIAL STATEMENTS FOR THE YEAR ENDED
DECEMBER 31, 2023, AND TRANSACTING SUCH OTHER BUSINESS AS MAY
PROPERLY COME BEFORE THE MEETING
At the Meeting, shareholders will have an opportunity to review, ask questions and comment on the Company's Consolidated Balance Sheet as of December 31, 2023, and the Consolidated
Statement of Income for the year then ended. The Company published its audited financial statements for the fiscal year ended December 31, 2023 on Form 6-K, which was filed with the Securities and Exchange Commission (the “SEC”) on March 18, 2024 and is available at their website, www.sec.gov, and also published such financial statements together with the Company's Annual Report on Form 20-F, which was filed with the SEC on April 30, 2024, and
is available at their website, and you may request that a copy be mailed to you. The Company will hold a discussion with respect to the Annual Report and financial statements at the Meeting. This agenda item will not involve a vote by the
shareholders.
Management is not aware of any other matters to be presented at the Meeting. If, however, any other matters should properly come before the Meeting or any adjournment or
postponement thereof, the proxy confers discretionary authority with respect to acting thereon, and the persons named in the enclosed proxy will vote on such matters in accordance with their best judgment.
Your vote is important! Shareholders are urged to complete and return their proxies promptly in order to, among other things, ensure action
by a quorum and to avoid the expense of additional solicitation. If the accompanying proxy is properly executed and returned in time for voting, and a choice is specified, the shares represented thereby will be voted as indicated thereon. EXCEPT AS
MENTIONED OTHERWISE IN THIS PROXY STATEMENT, IF NO SPECIFICATION IS MADE, THE PROXY WILL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS DESCRIBED IN THIS PROXY STATEMENT. Proxies and all other applicable materials should
be sent to the offices of the Company at 14 Atir Yeda Street, Kfar Sava 4464323, Israel (telephone number: 972-9-764-4555, facsimile number: 972-9-765-1977).
ADDITIONAL INFORMATION
We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as applicable to
foreign private issuers. Accordingly, we file reports and other information with the SEC. Shareholders may read and copy any document we file at the SEC's public reference rooms at 450 Fifth Street, N.W., Washington, D.C. 20549. Shareholders can call
the SEC at 1-800-SEC-0330 for further information on using the public reference room. In addition, similar information concerning us can be inspected and copied at the offices of the National Association of Securities Dealers, Inc., 9513 Key West
Avenue, Rockville, Maryland 20850 USA. All documents which we will file on the SEC's EDGAR system will be available for retrieval on the SEC's website at http://www.sec.gov. This proxy statement is also available on our website at http://www.silicom.co.il
and on the SEC's website at http://www.sec.gov.
As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing certain disclosure and procedural requirements for proxy solicitations. In addition, we
are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as United States companies whose securities are registered under the Exchange Act. The Notice of the Annual General
Meeting of Shareholders and the Proxy Statement have been prepared in accordance with applicable disclosure requirements in the State of Israel.
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROXY STATEMENT OR THE INFORMATION FURNISHED TO YOU IN CONNECTION WITH THIS PROXY STATEMENT WHEN VOTING ON THE MATTERS
SUBMITTED TO SHAREHOLDER APPROVAL HEREUNDER. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS DOCUMENT. THIS PROXY STATEMENT IS DATED MAY 7, 2024. YOU SHOULD NOT ASSUME THAT THE
INFORMATION CONTAINED IN THIS DOCUMENT IS ACCURATE AS OF ANY DATE OTHER THAN MAY 7, 2024, AND THE MAILING OF THIS DOCUMENT TO SHAREHOLDERS SHOULD NOT CREATE ANY IMPLICATION TO THE CONTRARY.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
